Skip to main content
Clinical Trials/JPRN-UMIN000022151
JPRN-UMIN000022151
Completed
未知

The efficacy and safety of mefloquine in patients with progressive multifocal leukoencephalopathy - The efficacy and safety of mefloquine in patients with progressive multifocal leukoencephalopathy

Department of Neurology, Shimane University Hospital0 sites5 target enrollmentApril 30, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Neurology, Shimane University Hospital
Enrollment
5
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 30, 2016
End Date
December 24, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Neurology, Shimane University Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients with other infection of the central nervous system. 2\) Physical status is severe or unstable. 3\) Patients with severe psychiatric disorder. 4\) Pregnant women or patients with possible pregnancy. 5\) Patients with a history of hypersensitivity to this drug.

Outcomes

Primary Outcomes

Not specified

Similar Trials